PERFORMANCE REVIEW: Q3FY13

20
PERFORMANCE REVIEW: Q3FY13 INVESTOR UPDATE

description

INVESTOR UPDATE. PERFORMANCE REVIEW: Q3FY13. Presentation Path. Aarti Industries – Profile Core Strengths Segmental overview Q3 FY13 Segmental Performance Condensed Statement of Operations Segmental Revenue Growth Trend Q3 FY13 Financial Highlights Segmental Revenue Growth Trend - PowerPoint PPT Presentation

Transcript of PERFORMANCE REVIEW: Q3FY13

Page 1: PERFORMANCE REVIEW: Q3FY13

PERFORMANCE REVIEW: Q3FY13

INVESTOR UPDATE

Page 2: PERFORMANCE REVIEW: Q3FY13

Presentation PathPresentation Path

• Aarti Industries – Profile

• Core Strengths

• Segmental overview

• Q3 FY13 Segmental Performance

• Condensed Statement of Operations

• Segmental Revenue Growth Trend

• Q3 FY13 Financial Highlights

• Segmental Revenue Growth Trend

• Financial Highlights – over 6 quarters

• Financial Highlights – Graphical Highlights

• Key Developments – Q3 FY13

• New Investment Plans

• Annexure / Back-up slides – Financial Statements

2

Page 3: PERFORMANCE REVIEW: Q3FY13

• Leading manufacturer of Speciality Chemicals &

Pharmaceuticals with diversified end-uses in Pharmaceuticals,

Agrochemicals, Polymer, Additives, Surfactants, Pigments, Dyes, etc.

• Promoters are First Generation Technocrats with sound

entrepreneurial Skills.

• Manufacturing units of Global Scale & Size and are situated in the

State of Gujarat, Maharashtra, Madhya Pradesh and U.T. of Silvassa.

• Highly integrated Plants with Cost-Efficient Manufacturing Process,.

• Pioneer to introduce latest technology and manufacturing processes

in India with the help of World Class R & D

• Globally ranks at 1st – 5th Position for majority of its key products

Aarti Industries - ProfileAarti Industries - Profile

3

Page 4: PERFORMANCE REVIEW: Q3FY13

Presence in high margin specialty chemicals with diverse applications

Global Scale Units

Manufacturing more than 125 products

Ability to Supply Basket of products to Global Customers & MNCs

Tagged as “Strategic Supplier” by various Global MNCs

Backward Integration

Latest Manufacturing Technology & World Class R&D

Superior Cost Management Skills & Economies of Scale

Capability to convert by-products into commercially viable product

IPRs for Developing Customized Products & Products under Secrecy Agreements

Captive Power Plants

Core StrengthsCore Strengths

4

Page 5: PERFORMANCE REVIEW: Q3FY13

Product & Process FlexibilityProduct & Process Flexibility

A significant portion of Aarti’s Production capabilities are process driven

and not based on a particular product. This gives Aarti the flexibility to

change its input mix and manufacture different products, thereby resulting

into optimum utilization of production capabilities

Brief Structure of Aarti Industries’ Production Capabilities

5

Page 6: PERFORMANCE REVIEW: Q3FY13

Segmental overviewSegmental overview

6

Page 7: PERFORMANCE REVIEW: Q3FY13

Q3 FY13 Segmental Performance Q3 FY13 Segmental Performance (standalone)(standalone)

ParticularsPerformance

Agro Pharma

H&PC

Total

Income 27,993 10,154 4,387 3,402 45,936

% of Total Income

60.94% 22.10% 9.55% 7.41%100.00

%

Export 15,349 5,080 1,729 383 22,540% of Sales 54.83% 50.03% 39.41% 11.26% 49.07%

EBIT 4,062 1,832 164 90 6,148

EBIT Margin 14.51% 18.05% 3.74% 2.63% 13.38%

In Rs. Lakh

7

Page 8: PERFORMANCE REVIEW: Q3FY13

Condensed Statement of OperationsCondensed Statement of Operations(standalone)(standalone)

ParticularsQ3FY1

3

% of Total

Income

Q3FY12

% of Total

Income

Y-o-Y Growth

(%)

Income from Operations 44,998 97.96% 40,667 97.29% 10.65%

Other Operating Income 938 2.04% 1,134 2.71% (17.28%)

Total Income 45,936 100.00% 41,801 100.00% 9.89%

• Exports 22,540 49.07% 19,007 45.47% 18.59%

Operating Expenditure 39,221 85.38% 35,236 84.29% 11.31%

EBITDA 6,715 14.62% 6,565 15.71% 2.28%

Depreciation 1,671 3.64% 1,368 3.27% 22.15%

Other Income 92 0.20% 25 0.06% 268.00%

EBIT 5,136 11.18% 5,222 12.49% (1.65%)

Finance Cost 2,054 4.47% 1,816 4.34% 13.11%

Profit Before Tax 3,082 6.71% 3,406 8.15% (9.51%)

Tax Expenses 900 1.96% 1,105 2.64% (18.55%)

Profit After Tax 2,182 4.75% 2,301 5.50% (5.17%)

In Rs. Lakh

8

Page 9: PERFORMANCE REVIEW: Q3FY13

Segmental Revenue Growth TrendSegmental Revenue Growth Trend(standalone)(standalone)

In Rs. Lakh

9

SegmentsQ1

FY12Q2

FY12Q3

FY12Q4

FY12

Annual

FY11-12

Q1FY13

Q2FY13

Q3FY13

Performance Chemicals

26,113 23,371 23,535 23,779 96,798 25,409 28,451 27,993

Agri-Intermediates & Fertilisers

6,047 8,441 10,072 13,670 38,230 10,466 10,384 10,154

Pharmaceuticals 3,565 3,834 4,128 4,935 16,462 4,803 4,284 4,387 Home & Personal Care

3,231 4,251 4,066 4,293 15,841 4,211 3,843 3,402

Total Income 38,956 39,897 41,801 46,677 167,331 44,889 46,962 45,936

Page 10: PERFORMANCE REVIEW: Q3FY13

Particulars

Q1FY12

Q2FY12

Q3FY12

Q4FY12

Annual FY11-

12

Q1FY13

Q2FY13

Q3FY13

Total Income

38,956 39,897 41,801 46,677 167,331 44,889 46,962 45,936

• Exports 16,450 16,484 19,007 20,835 72,776 21,749 23,645 22,540

% of Total Inc.

42.23%

41.32% 45.47% 44.64% 43.49% 48.45% 50.35% 49.07%

EBITDA 5,396 5,357 6,565 7,147 24,465 6,811 7,392 6,715

EBITDA Margin

13.85%

13.43% 15.71% 15.31% 14.62% 15.17% 15.74% 14.62%

EBIT 4,263 4,094 5,222 5,773 19,352 5,504 5,930 5,136

EBIT Margin

10.94%

10.26% 12.49% 12.37% 11.57% 12.26% 12.63% 11.18%

PAT 1,807 1,787 2,301 2,824 8,719 2,504 2,826 2,182

PAT Margin 4.64% 4.48% 5.50% 6.05% 5.21% 5.58% 6.02% 4.75%

EPS 2.36 2.33 3.00 3.68 11.36 3.16 3.57 2.76

In Rs. Lakh

Financial Highlights – over 7 quarters Financial Highlights – over 7 quarters (standalone)(standalone)

Page 11: PERFORMANCE REVIEW: Q3FY13

11

Financial Highlights – Graphical Layout…1Financial Highlights – Graphical Layout…1(standalone)(standalone)

Total Income (Rs. Lakh)

EBITDA (Rs. Lakh) & EBITDA as a % Net Profit (Rs. Lakh)

Exports (Rs. Lakh) & Exports as % of Total Income

Page 12: PERFORMANCE REVIEW: Q3FY13

12

Key developments in Q3FY13 Key developments in Q3FY13

Page 13: PERFORMANCE REVIEW: Q3FY13

13

Key developments in Q3FY13Key developments in Q3FY13

Page 14: PERFORMANCE REVIEW: Q3FY13

14

New InvestmentsNew Investments

Page 15: PERFORMANCE REVIEW: Q3FY13

15

Growth DriversGrowth Drivers

Page 16: PERFORMANCE REVIEW: Q3FY13

Thank YouThank YouFor further information please log on to www.aartigroup.com or contact:

Mr. Chetan Gandhi / Mrs. Mona PatelTel: +91 (22) 6797 6666; Email: [email protected]

Mr. Siddharth Kumar / Mr. Dhiraj RajpalMobile: +91 9833933447 / 9820106986Email: [email protected] / [email protected]

Page 17: PERFORMANCE REVIEW: Q3FY13

Annexure – Financial StatementsAnnexure – Financial Statements

17

Page 18: PERFORMANCE REVIEW: Q3FY13

18

Page 19: PERFORMANCE REVIEW: Q3FY13

19

Page 20: PERFORMANCE REVIEW: Q3FY13

Important DisclaimerImportant Disclaimer

• AARTI INDUSTRIES LIMITED may, from time to time, make additional written and oral forward looking statements, including statements contained in the company's filings with Bombay Stock Exchange and National Stock Exchange, and our reports to shareholders. The company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the AARTI INDUSTRIES LIMITED.

• All information contained in this presentation has been prepared solely by AARTI INDUSTRIES LIMITED. AARTI INDUSTRIES LIMITED does not accept any liability whatsoever for any loss, howsoever, arising from any use or reliance on this presentation or its contents or otherwise arising in connection therewith.

20